235 related articles for article (PubMed ID: 12370283)
1. Deletion of phosphodiesterase 4D in mice shortens alpha(2)-adrenoceptor-mediated anesthesia, a behavioral correlate of emesis.
Robichaud A; Stamatiou PB; Jin SL; Lachance N; MacDonald D; Laliberté F; Liu S; Huang Z; Conti M; Chan CC
J Clin Invest; 2002 Oct; 110(7):1045-52. PubMed ID: 12370283
[TBL] [Abstract][Full Text] [Related]
2. Assessing the emetic potential of PDE4 inhibitors in rats.
Robichaud A; Savoie C; Stamatiou PB; Lachance N; Jolicoeur P; Rasori R; Chan CC
Br J Pharmacol; 2002 Jan; 135(1):113-8. PubMed ID: 11786486
[TBL] [Abstract][Full Text] [Related]
3. PDE4 inhibitors induce emesis in ferrets via a noradrenergic pathway.
Robichaud A; Savoie C; Stamatiou PB; Tattersall FD; Chan CC
Neuropharmacology; 2001; 40(2):262-9. PubMed ID: 11114405
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme.
Zhang HT; Huang Y; Jin SL; Frith SA; Suvarna N; Conti M; O'Donnell JM
Neuropsychopharmacology; 2002 Oct; 27(4):587-95. PubMed ID: 12377395
[TBL] [Abstract][Full Text] [Related]
5. Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages.
Jin SL; Lan L; Zoudilova M; Conti M
J Immunol; 2005 Aug; 175(3):1523-31. PubMed ID: 16034090
[TBL] [Abstract][Full Text] [Related]
6. Luteolin, a non-selective competitive inhibitor of phosphodiesterases 1-5, displaced [3H]-rolipram from high-affinity rolipram binding sites and reversed xylazine/ketamine-induced anesthesia.
Yu MC; Chen JH; Lai CY; Han CY; Ko WC
Eur J Pharmacol; 2010 Feb; 627(1-3):269-75. PubMed ID: 19853596
[TBL] [Abstract][Full Text] [Related]
7. Nonredundant function of phosphodiesterases 4D and 4B in neutrophil recruitment to the site of inflammation.
Ariga M; Neitzert B; Nakae S; Mottin G; Bertrand C; Pruniaux MP; Jin SL; Conti M
J Immunol; 2004 Dec; 173(12):7531-8. PubMed ID: 15585880
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A
Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681
[TBL] [Abstract][Full Text] [Related]
9. The identification of a novel phosphodiesterase 4 inhibitor, 1-ethyl-5-{5-[(4-methyl-1-piperazinyl)methyl]-1,3,4-oxadiazol-2-yl}-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (EPPA-1), with improved therapeutic index using pica feeding in rats as a measure of emetogenicity.
Davis TG; Peterson JJ; Kou JP; Capper-Spudich EA; Ball D; Nials AT; Wiseman J; Solanke YE; Lucas FS; Williamson RA; Ferrari L; Wren P; Knowles RG; Barnette MS; Podolin PL
J Pharmacol Exp Ther; 2009 Sep; 330(3):922-31. PubMed ID: 19498103
[TBL] [Abstract][Full Text] [Related]
10. Differential expression and function of phosphodiesterase 4 (PDE4) subtypes in human primary CD4+ T cells: predominant role of PDE4D.
Peter D; Jin SL; Conti M; Hatzelmann A; Zitt C
J Immunol; 2007 Apr; 178(8):4820-31. PubMed ID: 17404263
[TBL] [Abstract][Full Text] [Related]
11. Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B.
Manning CD; Burman M; Christensen SB; Cieslinski LB; Essayan DM; Grous M; Torphy TJ; Barnette MS
Br J Pharmacol; 1999 Dec; 128(7):1393-8. PubMed ID: 10602317
[TBL] [Abstract][Full Text] [Related]
12. PDE4D plays a critical role in the control of airway smooth muscle contraction.
Méhats C; Jin SL; Wahlstrom J; Law E; Umetsu DT; Conti M
FASEB J; 2003 Oct; 17(13):1831-41. PubMed ID: 14519662
[TBL] [Abstract][Full Text] [Related]
13. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
Tiwari S; Dong H; Kim EJ; Weintraub L; Epstein PM; Lerner A
Biochem Pharmacol; 2005 Feb; 69(3):473-83. PubMed ID: 15652238
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling.
Li YF; Cheng YF; Huang Y; Conti M; Wilson SP; O'Donnell JM; Zhang HT
J Neurosci; 2011 Jan; 31(1):172-83. PubMed ID: 21209202
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of pyrrolo[2,3-d]pyridazinones as potent, subtype selective PDE4 inhibitors.
Giovannoni MP; Cesari N; Graziano A; Vergelli C; Biancalani C; Biagini P; Dal Piaz V
J Enzyme Inhib Med Chem; 2007 Jun; 22(3):309-18. PubMed ID: 17674813
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory and utero-relaxant effects in human myometrium of new generation phosphodiesterase 4 inhibitors.
Oger S; Méhats C; Barnette MS; Ferré F; Cabrol D; Leroy MJ
Biol Reprod; 2004 Feb; 70(2):458-64. PubMed ID: 14561639
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of a new cyclic nucleotide phosphodiesterase type 4 inhibitor, V11294.
Gale DD; Hofer P; Spina D; Seeds EA; Banner KH; Harrison S; Douglas G; Matsumoto T; Page CP; Wong RH; Jordan S; Smith F; Banik N; Halushka PV; Cavalla D; Rotshteyn Y; Kyle DJ; Burch RM; Chasin M
Pulm Pharmacol Ther; 2003; 16(2):97-104. PubMed ID: 12670778
[TBL] [Abstract][Full Text] [Related]
19. Studies on mechanisms of low emetogenicity of YM976, a novel phosphodiesterase type 4 inhibitor.
Aoki M; Fukunaga M; Sugimoto T; Hirano Y; Kobayashi M; Honda K; Yamada T
J Pharmacol Exp Ther; 2001 Sep; 298(3):1142-9. PubMed ID: 11504812
[TBL] [Abstract][Full Text] [Related]
20. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY
Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
